Carl Magnus Rudenstam
- Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93Carl Magnus Rudenstam
West Swedish Breast Cancer Study Group, Sahlgrenska University Hospital Molndal, Göteborgsvägen 31, 431 80 Mölndal, Sweden
J Clin Oncol 24:337-44. 2006..We therefore investigated whether avoiding axillary surgery in older women would result in improved quality of life (QL) with similar disease-free survival (DFS) and overall survival (OS)...
- The Gothenburg Breast Screening TrialNils Bjurstam
Department of Radiology, Center for Breast Imaging, University Hospital of North Norway, Tromsø, Norway
Cancer 97:2387-96. 2003..Although there is evidence for a reduction in breast carcinoma mortality with mammographic screening, some doubts have been expressed, and there is still uncertainty regarding the age specific effects...
- Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IVDiana Crivellari
Centro di Riferimento Oncologico, Via Pedemontana Occidentale 12, I 33081 Aviano, Italy
J Clin Oncol 21:4517-23. 2003..The role of adjuvant therapy for this population is still a matter of debate. We reviewed the long-term outcome of a mature trial comparing endocrine treatment versus no adjuvant therapy in older women with node-positive breast cancer...
- Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experienceMarco Colleoni
Division of Medical Oncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
J Clin Oncol 23:1390-400. 2005..For medial tumors, axillary lymph node staging may not accurately reflect the metastatic potential of the disease...
- Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast CaGünther Gruber
Department of Radiation Oncology, and the Institute of Medical Oncology, Inselspital, Switzerland
J Clin Oncol 23:7089-97. 2005..We sought to determine retrospectively whether extracapsular spread (ECS) might identify a subgroup that could benefit from radiotherapy after mastectomy, especially patients with 1 to 3 positive lymph nodes (LN1-3+)...
- Increased risk of recurrence after hormone replacement therapy in breast cancer survivorsLars Holmberg
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
J Natl Cancer Inst 100:475-82. 2008..We present results after extended follow-up...